Pornngarm Limtrakul
Overview
Explore the profile of Pornngarm Limtrakul including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
1132
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
41.
Yodkeeree S, Chaiwangyen W, Garbisa S, Limtrakul P
J Nutr Biochem
. 2008 May;
20(2):87-95.
PMID: 18495463
Curcumin (Cur), a component of turmeric (Curcuma longa), has been reported to exhibit antimetastatic activities, but the mechanisms remain unclear. Other curcuminoids present in turmeric, demethoxycurcumin (DMC) and bisdemethoxycurcumin (BDMC)...
42.
Anuchapreeda S, Tima S, Duangrat C, Limtrakul P
Cancer Chemother Pharmacol
. 2007 Nov;
62(4):585-94.
PMID: 18034345
Purpose: Leukemias are groups of hematological malignancies with high incidence and mortality rates in patients worldwide. There have been shown in many studies that Wilms' tumor1 (WT1) gene were highly...
43.
Limtrakul P
Adv Exp Med Biol
. 2007 Jun;
595:269-300.
PMID: 17569216
This overview presents curcumin as a significant chemosensitizer in cancer chemotherapy. Although the review focuses on curcumin and its analogues on multidrug resistance (MDR) reversal, the relevance of curcumin as...
44.
Sandur S, Pandey M, Sung B, Ahn K, Murakami A, Sethi G, et al.
Carcinogenesis
. 2007 May;
28(8):1765-73.
PMID: 17522064
Curcumin, a component of turmeric (Curcuma longa), has been shown to exhibit chemopreventive activity. Whether analogs of curcumin (Cur), such as demethoxycurcumin (DMC), bisdemethoxycurcumin (BDMC), tetrahydrocurcumin (THC) and turmerones, modulate...
45.
Anuchapreeda S, Thanarattanakorn P, Sittipreechacharn S, Tima S, Chanarat P, Limtrakul P
Arch Pharm Res
. 2006 Nov;
29(10):866-73.
PMID: 17121181
When patients with cancers are treated with chemotherapeutic agents a long time, some of the cancer cells develop the multidrug resistance (MDR) phenotype. MDR cancer cells are characterized by the...
46.
Limtrakul P, Chearwae W, Shukla S, Phisalphong C, Ambudkar S
Mol Cell Biochem
. 2006 Sep;
296(1-2):85-95.
PMID: 16960658
Many studies have been performed with the aim of developing effective resistance modulators to overcome the multidrug resistance (MDR) of human cancers. Potent MDR modulators are being investigated in clinical...
47.
Chearwae W, Shukla S, Limtrakul P, Ambudkar S
Mol Cancer Ther
. 2006 Aug;
5(8):1995-2006.
PMID: 16928820
Curcumin (curcumin I), demethoxycurcumin (curcumin II), and bisdemethoxycurcumin (curcumin III) are the major forms of curcuminoids found in the turmeric powder, which exhibit anticancer, antioxidant, and anti-inflammatory activities. In this...
48.
Anuchapreeda S, Limtrakul P, Thanarattanakorn P, Sittipreechacharn S, Chanarat P
Arch Pharm Res
. 2006 Feb;
29(1):80-7.
PMID: 16491848
Leukemias are common worldwide. Wilms' tumor1 (WT1) protein is highly expressed in leukemic blast cells of myeloid and lymphoid origin. Thus, WT1 mRNA serves as a tumor marker for leukemias...
49.
Anuchapreeda S, Thanarattanakorn P, Sittipreechacharn S, Chanarat P, Limtrakul P
Acta Pharmacol Sin
. 2006 Feb;
27(3):360-6.
PMID: 16490174
Aim: Wilms' tumor1 (WT1) gene is highly expressed in leukemic blast cells of myeloid and lymphoid origin. Thus, WT1 mRNA and protein serve as promising tumor markers for the detection...
50.
Chearwae W, Wu C, Chu H, Lee T, Ambudkar S, Limtrakul P
Cancer Chemother Pharmacol
. 2005 Jul;
57(3):376-88.
PMID: 16021489
Multidrug resistance is a major cause of chemotherapy failure in cancer patients. One of the resistance mechanisms is the overexpression of drug efflux pumps such as P-glycoprotein and multidrug resistance...